Leaflet ALVESCO 160 INHALER 160mcg / dose pressurized inhalation solution

Indicated for: asthma; allergic rhinitis

Route of administration: inhalation

Substance: ciclesonide (glucocorticoid)

ATC: R03BA08 (Respiratory system | Other drugs for obstructive airway diseases, inhalants | Glucocorticoids)

Ciclesonide is a glucocorticoid used for the treatment of asthma and allergic rhinitis. It works by reducing inflammation in the airways, alleviating symptoms such as breathing difficulties and nasal congestion.

The medication is administered as an inhaler or nasal spray, as directed by a doctor. It is important for patients to use the medication regularly to achieve maximum benefits.

Patients should be aware of potential side effects, such as throat irritation, hoarseness, or nasal dryness. It is important to inform the doctor of any unusual symptoms.

Common side effects include throat irritation, hoarseness, and nasal dryness. In rare cases, severe reactions such as oral fungal infections or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about ALVESCO 160 INHALER 160mcg / dose

  • Substance: ciclesonide
  • Date of latest medicines list: 01-06-2026
  • Product code: W67523002
  • Concentration: 160mcg / dose
  • Pharmaceutical form: pressurized inhalation solution
  • Quantity: 1
  • Product type: Original
  • Price: 166.84 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: TAKEDA GMBH - GERMANIA
  • Holder: COVIS PHARMA EUROPE B.V. - OLANDA
  • Number: 9031/2016/02
  • Shelf life: 3 years

Concentrations available for ciclesonide

  • 160mcg/dose
  • 40mcg/dose
  • 80mcg/dose

Compensation lists for ALVESCO 160 INHALER 160mcg / dose Covis Pharma Europe

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

166.84 RON

83.42 RON

83.42 RON